Review



nsc34 neurons  (Cedarlane)


Bioz Verified Symbol Cedarlane is a verified supplier
Bioz Manufacturer Symbol Cedarlane manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cedarlane nsc34 neurons
    PTEN -siRNA nanoparticle transfection enables efficient gene silencing with minimal impact on neuron health (A) PTEN -siRNA nanoparticles (100 nM) demonstrated highly efficient knockdown of target PTEN mRNA in differentiated <t>NSC34</t> neurons, with peak knockdown on Day 3 for the delivered siRNA [t(2) = −4.840, p = 0.02007; one-tailed] with expression levels returning to baseline by Day 7 [t(2) = 0.05373, p = 0.5190; one-tailed]. RNA fold change and associated error was assessed using the 2 −ΔΔCt method and normalized to GAPDH as per (B) Treatment of neurons with PTEN- siRNA nanoparticles at 100 nM had a non-significant effect on the metabolic activity at 3 [t(2) = 0.6370, p = 0.5893, 95 % CI 74.4820<x <134.3874] and 7 days [t(2) = −3.390, p = 0.07708, 95 % CI -66.21<x<104.0] post-transfection. (C – F) Transfection of PTEN -siRNA nanoparticles does not affect neuronal morphology. Control and PTEN -siRNA nanoparticle treated neurons have a similar distribution, density, and morphology compared to control neurons (C, D). Higher magnification images showed that all neurons (control and treated) possessed a typical neuronal morphology with several neurites extending from each cell body (E, F). All cells were stained for F-actin (green = phalloidin) and nuclei (blue = DAPI). Scale Bar in (C, D): 100 μm; Scale Bar in (E, F): 50 μm. Significance code: ns = p > 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.
    Nsc34 Neurons, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 67 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nsc34 neurons/product/Cedarlane
    Average 93 stars, based on 67 article reviews
    nsc34 neurons - by Bioz Stars, 2026-06
    93/100 stars

    Images

    1) Product Images from "Development of a PTEN -siRNA activated scaffold to promote axonal regrowth following spinal cord injury"

    Article Title: Development of a PTEN -siRNA activated scaffold to promote axonal regrowth following spinal cord injury

    Journal: Bioactive Materials

    doi: 10.1016/j.bioactmat.2026.01.022

    PTEN -siRNA nanoparticle transfection enables efficient gene silencing with minimal impact on neuron health (A) PTEN -siRNA nanoparticles (100 nM) demonstrated highly efficient knockdown of target PTEN mRNA in differentiated NSC34 neurons, with peak knockdown on Day 3 for the delivered siRNA [t(2) = −4.840, p = 0.02007; one-tailed] with expression levels returning to baseline by Day 7 [t(2) = 0.05373, p = 0.5190; one-tailed]. RNA fold change and associated error was assessed using the 2 −ΔΔCt method and normalized to GAPDH as per (B) Treatment of neurons with PTEN- siRNA nanoparticles at 100 nM had a non-significant effect on the metabolic activity at 3 [t(2) = 0.6370, p = 0.5893, 95 % CI 74.4820<x <134.3874] and 7 days [t(2) = −3.390, p = 0.07708, 95 % CI -66.21<x<104.0] post-transfection. (C – F) Transfection of PTEN -siRNA nanoparticles does not affect neuronal morphology. Control and PTEN -siRNA nanoparticle treated neurons have a similar distribution, density, and morphology compared to control neurons (C, D). Higher magnification images showed that all neurons (control and treated) possessed a typical neuronal morphology with several neurites extending from each cell body (E, F). All cells were stained for F-actin (green = phalloidin) and nuclei (blue = DAPI). Scale Bar in (C, D): 100 μm; Scale Bar in (E, F): 50 μm. Significance code: ns = p > 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.
    Figure Legend Snippet: PTEN -siRNA nanoparticle transfection enables efficient gene silencing with minimal impact on neuron health (A) PTEN -siRNA nanoparticles (100 nM) demonstrated highly efficient knockdown of target PTEN mRNA in differentiated NSC34 neurons, with peak knockdown on Day 3 for the delivered siRNA [t(2) = −4.840, p = 0.02007; one-tailed] with expression levels returning to baseline by Day 7 [t(2) = 0.05373, p = 0.5190; one-tailed]. RNA fold change and associated error was assessed using the 2 −ΔΔCt method and normalized to GAPDH as per (B) Treatment of neurons with PTEN- siRNA nanoparticles at 100 nM had a non-significant effect on the metabolic activity at 3 [t(2) = 0.6370, p = 0.5893, 95 % CI 74.4820 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.

    Techniques Used: Transfection, Knockdown, One-tailed Test, Expressing, Activity Assay, Control, Staining

    Scaffold-mediated siRNA delivery does not affect the viability of neurons, results in prolonged downregulation of PTEN, and stimulates increased expression of BCL2 and GAP43 mRNA . (A) The metabolic activity of NSC34 neurons cultured on PTEN -siRNA activated scaffolds peaked by day 3 post-transfection [t(2) = 4.0599, p = 0.05565, 95 % CI 93.954<x<308.3], decreased by day 7 [t(2) = −15.068, p = 0.004375, 95 % CI 49.7157<x<72.05] and was similar to control levels by day 21 [t(2) = −0.1042, p = 0.9265, 95 % CI 83.23<x<116.0]. Metabolic activity normalization was performed relative to the untreated cells. (B) LDH assay revealed a consistent but small increase in cell stress over a span of 21 days. (C – D) Analysis of PTEN gene expression in scaffold transfected neurons over 21 days showed a significant decrease in expression levels [t(4) = −3.2927, p = 0.01507; one-tailed] 3 days after transfection that was then followed by a gradual return toward untreated control levels denoted by the blue regression line which approaches the red untreated control line after 21 days. (E – F) The change in BCL2 expression 3-, 7-, and 21-days post-transfection showed a significant initial elevation [t(4) = 2.092, p = 0.05227, one-tailed], followed by a gradual reduction converging toward untreated control levels. (G – H). Similarly, GAP43 expression was characterised by of an initial significant rise [t(4) = 2.1748, p = 0.04765, one-tailed] in levels that was followed by a decrease over the 21-day culture period. Significance code: ns = p > 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.
    Figure Legend Snippet: Scaffold-mediated siRNA delivery does not affect the viability of neurons, results in prolonged downregulation of PTEN, and stimulates increased expression of BCL2 and GAP43 mRNA . (A) The metabolic activity of NSC34 neurons cultured on PTEN -siRNA activated scaffolds peaked by day 3 post-transfection [t(2) = 4.0599, p = 0.05565, 95 % CI 93.954 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.

    Techniques Used: Expressing, Activity Assay, Cell Culture, Transfection, Control, Lactate Dehydrogenase Assay, Gene Expression, One-tailed Test



    Similar Products

    93
    Cedarlane nsc34 neurons
    PTEN -siRNA nanoparticle transfection enables efficient gene silencing with minimal impact on neuron health (A) PTEN -siRNA nanoparticles (100 nM) demonstrated highly efficient knockdown of target PTEN mRNA in differentiated <t>NSC34</t> neurons, with peak knockdown on Day 3 for the delivered siRNA [t(2) = −4.840, p = 0.02007; one-tailed] with expression levels returning to baseline by Day 7 [t(2) = 0.05373, p = 0.5190; one-tailed]. RNA fold change and associated error was assessed using the 2 −ΔΔCt method and normalized to GAPDH as per (B) Treatment of neurons with PTEN- siRNA nanoparticles at 100 nM had a non-significant effect on the metabolic activity at 3 [t(2) = 0.6370, p = 0.5893, 95 % CI 74.4820<x <134.3874] and 7 days [t(2) = −3.390, p = 0.07708, 95 % CI -66.21<x<104.0] post-transfection. (C – F) Transfection of PTEN -siRNA nanoparticles does not affect neuronal morphology. Control and PTEN -siRNA nanoparticle treated neurons have a similar distribution, density, and morphology compared to control neurons (C, D). Higher magnification images showed that all neurons (control and treated) possessed a typical neuronal morphology with several neurites extending from each cell body (E, F). All cells were stained for F-actin (green = phalloidin) and nuclei (blue = DAPI). Scale Bar in (C, D): 100 μm; Scale Bar in (E, F): 50 μm. Significance code: ns = p > 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.
    Nsc34 Neurons, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nsc34 neurons/product/Cedarlane
    Average 93 stars, based on 1 article reviews
    nsc34 neurons - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    Cedarlane nsc34 cells
    PTEN -siRNA nanoparticle transfection enables efficient gene silencing with minimal impact on neuron health (A) PTEN -siRNA nanoparticles (100 nM) demonstrated highly efficient knockdown of target PTEN mRNA in differentiated <t>NSC34</t> neurons, with peak knockdown on Day 3 for the delivered siRNA [t(2) = −4.840, p = 0.02007; one-tailed] with expression levels returning to baseline by Day 7 [t(2) = 0.05373, p = 0.5190; one-tailed]. RNA fold change and associated error was assessed using the 2 −ΔΔCt method and normalized to GAPDH as per (B) Treatment of neurons with PTEN- siRNA nanoparticles at 100 nM had a non-significant effect on the metabolic activity at 3 [t(2) = 0.6370, p = 0.5893, 95 % CI 74.4820<x <134.3874] and 7 days [t(2) = −3.390, p = 0.07708, 95 % CI -66.21<x<104.0] post-transfection. (C – F) Transfection of PTEN -siRNA nanoparticles does not affect neuronal morphology. Control and PTEN -siRNA nanoparticle treated neurons have a similar distribution, density, and morphology compared to control neurons (C, D). Higher magnification images showed that all neurons (control and treated) possessed a typical neuronal morphology with several neurites extending from each cell body (E, F). All cells were stained for F-actin (green = phalloidin) and nuclei (blue = DAPI). Scale Bar in (C, D): 100 μm; Scale Bar in (E, F): 50 μm. Significance code: ns = p > 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.
    Nsc34 Cells, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nsc34 cells/product/Cedarlane
    Average 93 stars, based on 1 article reviews
    nsc34 cells - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    Cedarlane nsc34 cells cedarlane cat
    PTEN -siRNA nanoparticle transfection enables efficient gene silencing with minimal impact on neuron health (A) PTEN -siRNA nanoparticles (100 nM) demonstrated highly efficient knockdown of target PTEN mRNA in differentiated <t>NSC34</t> neurons, with peak knockdown on Day 3 for the delivered siRNA [t(2) = −4.840, p = 0.02007; one-tailed] with expression levels returning to baseline by Day 7 [t(2) = 0.05373, p = 0.5190; one-tailed]. RNA fold change and associated error was assessed using the 2 −ΔΔCt method and normalized to GAPDH as per (B) Treatment of neurons with PTEN- siRNA nanoparticles at 100 nM had a non-significant effect on the metabolic activity at 3 [t(2) = 0.6370, p = 0.5893, 95 % CI 74.4820<x <134.3874] and 7 days [t(2) = −3.390, p = 0.07708, 95 % CI -66.21<x<104.0] post-transfection. (C – F) Transfection of PTEN -siRNA nanoparticles does not affect neuronal morphology. Control and PTEN -siRNA nanoparticle treated neurons have a similar distribution, density, and morphology compared to control neurons (C, D). Higher magnification images showed that all neurons (control and treated) possessed a typical neuronal morphology with several neurites extending from each cell body (E, F). All cells were stained for F-actin (green = phalloidin) and nuclei (blue = DAPI). Scale Bar in (C, D): 100 μm; Scale Bar in (E, F): 50 μm. Significance code: ns = p > 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.
    Nsc34 Cells Cedarlane Cat, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nsc34 cells cedarlane cat/product/Cedarlane
    Average 93 stars, based on 1 article reviews
    nsc34 cells cedarlane cat - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    Cedarlane nsc34 murine motor neuron like cell line
    PTEN -siRNA nanoparticle transfection enables efficient gene silencing with minimal impact on neuron health (A) PTEN -siRNA nanoparticles (100 nM) demonstrated highly efficient knockdown of target PTEN mRNA in differentiated <t>NSC34</t> neurons, with peak knockdown on Day 3 for the delivered siRNA [t(2) = −4.840, p = 0.02007; one-tailed] with expression levels returning to baseline by Day 7 [t(2) = 0.05373, p = 0.5190; one-tailed]. RNA fold change and associated error was assessed using the 2 −ΔΔCt method and normalized to GAPDH as per (B) Treatment of neurons with PTEN- siRNA nanoparticles at 100 nM had a non-significant effect on the metabolic activity at 3 [t(2) = 0.6370, p = 0.5893, 95 % CI 74.4820<x <134.3874] and 7 days [t(2) = −3.390, p = 0.07708, 95 % CI -66.21<x<104.0] post-transfection. (C – F) Transfection of PTEN -siRNA nanoparticles does not affect neuronal morphology. Control and PTEN -siRNA nanoparticle treated neurons have a similar distribution, density, and morphology compared to control neurons (C, D). Higher magnification images showed that all neurons (control and treated) possessed a typical neuronal morphology with several neurites extending from each cell body (E, F). All cells were stained for F-actin (green = phalloidin) and nuclei (blue = DAPI). Scale Bar in (C, D): 100 μm; Scale Bar in (E, F): 50 μm. Significance code: ns = p > 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.
    Nsc34 Murine Motor Neuron Like Cell Line, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nsc34 murine motor neuron like cell line/product/Cedarlane
    Average 93 stars, based on 1 article reviews
    nsc34 murine motor neuron like cell line - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    Cedarlane nsc34 mouse motor neuronal cells
    PTEN -siRNA nanoparticle transfection enables efficient gene silencing with minimal impact on neuron health (A) PTEN -siRNA nanoparticles (100 nM) demonstrated highly efficient knockdown of target PTEN mRNA in differentiated <t>NSC34</t> neurons, with peak knockdown on Day 3 for the delivered siRNA [t(2) = −4.840, p = 0.02007; one-tailed] with expression levels returning to baseline by Day 7 [t(2) = 0.05373, p = 0.5190; one-tailed]. RNA fold change and associated error was assessed using the 2 −ΔΔCt method and normalized to GAPDH as per (B) Treatment of neurons with PTEN- siRNA nanoparticles at 100 nM had a non-significant effect on the metabolic activity at 3 [t(2) = 0.6370, p = 0.5893, 95 % CI 74.4820<x <134.3874] and 7 days [t(2) = −3.390, p = 0.07708, 95 % CI -66.21<x<104.0] post-transfection. (C – F) Transfection of PTEN -siRNA nanoparticles does not affect neuronal morphology. Control and PTEN -siRNA nanoparticle treated neurons have a similar distribution, density, and morphology compared to control neurons (C, D). Higher magnification images showed that all neurons (control and treated) possessed a typical neuronal morphology with several neurites extending from each cell body (E, F). All cells were stained for F-actin (green = phalloidin) and nuclei (blue = DAPI). Scale Bar in (C, D): 100 μm; Scale Bar in (E, F): 50 μm. Significance code: ns = p > 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.
    Nsc34 Mouse Motor Neuronal Cells, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nsc34 mouse motor neuronal cells/product/Cedarlane
    Average 93 stars, based on 1 article reviews
    nsc34 mouse motor neuronal cells - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    Cedarlane nsc34 motor neuron cell line
    PTEN -siRNA nanoparticle transfection enables efficient gene silencing with minimal impact on neuron health (A) PTEN -siRNA nanoparticles (100 nM) demonstrated highly efficient knockdown of target PTEN mRNA in differentiated <t>NSC34</t> neurons, with peak knockdown on Day 3 for the delivered siRNA [t(2) = −4.840, p = 0.02007; one-tailed] with expression levels returning to baseline by Day 7 [t(2) = 0.05373, p = 0.5190; one-tailed]. RNA fold change and associated error was assessed using the 2 −ΔΔCt method and normalized to GAPDH as per (B) Treatment of neurons with PTEN- siRNA nanoparticles at 100 nM had a non-significant effect on the metabolic activity at 3 [t(2) = 0.6370, p = 0.5893, 95 % CI 74.4820<x <134.3874] and 7 days [t(2) = −3.390, p = 0.07708, 95 % CI -66.21<x<104.0] post-transfection. (C – F) Transfection of PTEN -siRNA nanoparticles does not affect neuronal morphology. Control and PTEN -siRNA nanoparticle treated neurons have a similar distribution, density, and morphology compared to control neurons (C, D). Higher magnification images showed that all neurons (control and treated) possessed a typical neuronal morphology with several neurites extending from each cell body (E, F). All cells were stained for F-actin (green = phalloidin) and nuclei (blue = DAPI). Scale Bar in (C, D): 100 μm; Scale Bar in (E, F): 50 μm. Significance code: ns = p > 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.
    Nsc34 Motor Neuron Cell Line, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nsc34 motor neuron cell line/product/Cedarlane
    Average 93 stars, based on 1 article reviews
    nsc34 motor neuron cell line - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    Cedarlane nsc34 cell line
    Fig. 3. Overexpression of RBM5 induces motor neurons apoptosis. (A) Western blotting analysis and qRT-PCR were performed to assess the efficiency of RBM5 overexpression (n=3). (B) Flow cytometry was employed to assess the apoptosis of <t>NSC34</t> cells following transfection with RBM5 or EV plasmid for 48 h (n=3). (C) TUNEL staining of NSC34 cells after treatment with RBM5 or EV plasmid (n=3). (D) Cell viability was quantified using CCK-8 (n=5). Data are presented as means ± SD. Statistical analysis was performed using student’s t-test. *p<0.05, **p<0.01, ***p<0.001.
    Nsc34 Cell Line, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nsc34 cell line/product/Cedarlane
    Average 93 stars, based on 1 article reviews
    nsc34 cell line - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    90
    CELLutions Biosystems motor neuron-like cell line nsc34
    Fig. 3. Overexpression of RBM5 induces motor neurons apoptosis. (A) Western blotting analysis and qRT-PCR were performed to assess the efficiency of RBM5 overexpression (n=3). (B) Flow cytometry was employed to assess the apoptosis of <t>NSC34</t> cells following transfection with RBM5 or EV plasmid for 48 h (n=3). (C) TUNEL staining of NSC34 cells after treatment with RBM5 or EV plasmid (n=3). (D) Cell viability was quantified using CCK-8 (n=5). Data are presented as means ± SD. Statistical analysis was performed using student’s t-test. *p<0.05, **p<0.01, ***p<0.001.
    Motor Neuron Like Cell Line Nsc34, supplied by CELLutions Biosystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/motor neuron-like cell line nsc34/product/CELLutions Biosystems
    Average 90 stars, based on 1 article reviews
    motor neuron-like cell line nsc34 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    CELLutions Biosystems nsc34 cell lines (mouse motor neuron-like)
    Sequence coverage map of VDAC3 from <t>NSC34,</t> NSC34-SOD1WT and NSC34-SOD1G93A cell lines obtained by tryptic and chymotryptic digestion. The solid line indicates the sequence that was obtained from tryptic peptides; dotted lines: sequence obtained from chymotryptic peptides. Unique tryptic (indicated in bold and blue) and chymotryptic (indicated in bold and black) peptides originating from missed cleavages were used to distinguish and cover the sequences shared by isoforms. Sequences shared by multiple isoforms are shown in red. Sequence numbering considered the starting methionine residue, which is eliminated during protein maturation.
    Nsc34 Cell Lines (Mouse Motor Neuron Like), supplied by CELLutions Biosystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nsc34 cell lines (mouse motor neuron-like)/product/CELLutions Biosystems
    Average 90 stars, based on 1 article reviews
    nsc34 cell lines (mouse motor neuron-like) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    PTEN -siRNA nanoparticle transfection enables efficient gene silencing with minimal impact on neuron health (A) PTEN -siRNA nanoparticles (100 nM) demonstrated highly efficient knockdown of target PTEN mRNA in differentiated NSC34 neurons, with peak knockdown on Day 3 for the delivered siRNA [t(2) = −4.840, p = 0.02007; one-tailed] with expression levels returning to baseline by Day 7 [t(2) = 0.05373, p = 0.5190; one-tailed]. RNA fold change and associated error was assessed using the 2 −ΔΔCt method and normalized to GAPDH as per (B) Treatment of neurons with PTEN- siRNA nanoparticles at 100 nM had a non-significant effect on the metabolic activity at 3 [t(2) = 0.6370, p = 0.5893, 95 % CI 74.4820<x <134.3874] and 7 days [t(2) = −3.390, p = 0.07708, 95 % CI -66.21<x<104.0] post-transfection. (C – F) Transfection of PTEN -siRNA nanoparticles does not affect neuronal morphology. Control and PTEN -siRNA nanoparticle treated neurons have a similar distribution, density, and morphology compared to control neurons (C, D). Higher magnification images showed that all neurons (control and treated) possessed a typical neuronal morphology with several neurites extending from each cell body (E, F). All cells were stained for F-actin (green = phalloidin) and nuclei (blue = DAPI). Scale Bar in (C, D): 100 μm; Scale Bar in (E, F): 50 μm. Significance code: ns = p > 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.

    Journal: Bioactive Materials

    Article Title: Development of a PTEN -siRNA activated scaffold to promote axonal regrowth following spinal cord injury

    doi: 10.1016/j.bioactmat.2026.01.022

    Figure Lengend Snippet: PTEN -siRNA nanoparticle transfection enables efficient gene silencing with minimal impact on neuron health (A) PTEN -siRNA nanoparticles (100 nM) demonstrated highly efficient knockdown of target PTEN mRNA in differentiated NSC34 neurons, with peak knockdown on Day 3 for the delivered siRNA [t(2) = −4.840, p = 0.02007; one-tailed] with expression levels returning to baseline by Day 7 [t(2) = 0.05373, p = 0.5190; one-tailed]. RNA fold change and associated error was assessed using the 2 −ΔΔCt method and normalized to GAPDH as per (B) Treatment of neurons with PTEN- siRNA nanoparticles at 100 nM had a non-significant effect on the metabolic activity at 3 [t(2) = 0.6370, p = 0.5893, 95 % CI 74.4820 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.

    Article Snippet: NSC34 neuronal culture and transfections: NSC34 neurons (Cedarlane Cat No. CLU140), a hybrid cell line produced by the fusion of motor neuron enriched embryonic mouse spinal cord cells with mouse neuroblastoma cells, were cultured in growth medium Dulbecco's Modified Eagle Medium (DMEM; Sigma-Aldrich, Ireland) supplemented with 10 % fetal bovine serum (FBS; Labtech UK), 1 % (v/v) L-Glutamine (Sigma-Aldrich, Ireland), and 1 % (v/v) Penicillin- Streptomycin Solution (Sigma-Aldrich, Ireland) in a T-175 cell culture flask (37 °C, 5 % CO 2 ).

    Techniques: Transfection, Knockdown, One-tailed Test, Expressing, Activity Assay, Control, Staining

    Scaffold-mediated siRNA delivery does not affect the viability of neurons, results in prolonged downregulation of PTEN, and stimulates increased expression of BCL2 and GAP43 mRNA . (A) The metabolic activity of NSC34 neurons cultured on PTEN -siRNA activated scaffolds peaked by day 3 post-transfection [t(2) = 4.0599, p = 0.05565, 95 % CI 93.954<x<308.3], decreased by day 7 [t(2) = −15.068, p = 0.004375, 95 % CI 49.7157<x<72.05] and was similar to control levels by day 21 [t(2) = −0.1042, p = 0.9265, 95 % CI 83.23<x<116.0]. Metabolic activity normalization was performed relative to the untreated cells. (B) LDH assay revealed a consistent but small increase in cell stress over a span of 21 days. (C – D) Analysis of PTEN gene expression in scaffold transfected neurons over 21 days showed a significant decrease in expression levels [t(4) = −3.2927, p = 0.01507; one-tailed] 3 days after transfection that was then followed by a gradual return toward untreated control levels denoted by the blue regression line which approaches the red untreated control line after 21 days. (E – F) The change in BCL2 expression 3-, 7-, and 21-days post-transfection showed a significant initial elevation [t(4) = 2.092, p = 0.05227, one-tailed], followed by a gradual reduction converging toward untreated control levels. (G – H). Similarly, GAP43 expression was characterised by of an initial significant rise [t(4) = 2.1748, p = 0.04765, one-tailed] in levels that was followed by a decrease over the 21-day culture period. Significance code: ns = p > 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.

    Journal: Bioactive Materials

    Article Title: Development of a PTEN -siRNA activated scaffold to promote axonal regrowth following spinal cord injury

    doi: 10.1016/j.bioactmat.2026.01.022

    Figure Lengend Snippet: Scaffold-mediated siRNA delivery does not affect the viability of neurons, results in prolonged downregulation of PTEN, and stimulates increased expression of BCL2 and GAP43 mRNA . (A) The metabolic activity of NSC34 neurons cultured on PTEN -siRNA activated scaffolds peaked by day 3 post-transfection [t(2) = 4.0599, p = 0.05565, 95 % CI 93.954 0.1; • = p ≤ 0.1, ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗∗∗ = p ≤ 0.001, ∗∗∗∗ = p ≤ 0.0001.

    Article Snippet: NSC34 neuronal culture and transfections: NSC34 neurons (Cedarlane Cat No. CLU140), a hybrid cell line produced by the fusion of motor neuron enriched embryonic mouse spinal cord cells with mouse neuroblastoma cells, were cultured in growth medium Dulbecco's Modified Eagle Medium (DMEM; Sigma-Aldrich, Ireland) supplemented with 10 % fetal bovine serum (FBS; Labtech UK), 1 % (v/v) L-Glutamine (Sigma-Aldrich, Ireland), and 1 % (v/v) Penicillin- Streptomycin Solution (Sigma-Aldrich, Ireland) in a T-175 cell culture flask (37 °C, 5 % CO 2 ).

    Techniques: Expressing, Activity Assay, Cell Culture, Transfection, Control, Lactate Dehydrogenase Assay, Gene Expression, One-tailed Test

    Fig. 3. Overexpression of RBM5 induces motor neurons apoptosis. (A) Western blotting analysis and qRT-PCR were performed to assess the efficiency of RBM5 overexpression (n=3). (B) Flow cytometry was employed to assess the apoptosis of NSC34 cells following transfection with RBM5 or EV plasmid for 48 h (n=3). (C) TUNEL staining of NSC34 cells after treatment with RBM5 or EV plasmid (n=3). (D) Cell viability was quantified using CCK-8 (n=5). Data are presented as means ± SD. Statistical analysis was performed using student’s t-test. *p<0.05, **p<0.01, ***p<0.001.

    Journal: Brain research bulletin

    Article Title: RBM5 induces motor neuron apoptosis in hSOD1 G93A -related amyotrophic lateral sclerosis by inhibiting Rac1/AKT pathways.

    doi: 10.1016/j.brainresbull.2024.111049

    Figure Lengend Snippet: Fig. 3. Overexpression of RBM5 induces motor neurons apoptosis. (A) Western blotting analysis and qRT-PCR were performed to assess the efficiency of RBM5 overexpression (n=3). (B) Flow cytometry was employed to assess the apoptosis of NSC34 cells following transfection with RBM5 or EV plasmid for 48 h (n=3). (C) TUNEL staining of NSC34 cells after treatment with RBM5 or EV plasmid (n=3). (D) Cell viability was quantified using CCK-8 (n=5). Data are presented as means ± SD. Statistical analysis was performed using student’s t-test. *p<0.05, **p<0.01, ***p<0.001.

    Article Snippet: The NSC34 cell line (Cedarlane Laboratories, Vancouver, Canada) is a hybrid of embryonic mouse neuroblastoma and spinal cord motor neurons.

    Techniques: Over Expression, Western Blot, Quantitative RT-PCR, Flow Cytometry, Transfection, Plasmid Preparation, TUNEL Assay, Staining, CCK-8 Assay

    Sequence coverage map of VDAC3 from NSC34, NSC34-SOD1WT and NSC34-SOD1G93A cell lines obtained by tryptic and chymotryptic digestion. The solid line indicates the sequence that was obtained from tryptic peptides; dotted lines: sequence obtained from chymotryptic peptides. Unique tryptic (indicated in bold and blue) and chymotryptic (indicated in bold and black) peptides originating from missed cleavages were used to distinguish and cover the sequences shared by isoforms. Sequences shared by multiple isoforms are shown in red. Sequence numbering considered the starting methionine residue, which is eliminated during protein maturation.

    Journal: International Journal of Molecular Sciences

    Article Title: Specific Post-Translational Modifications of VDAC3 in ALS-SOD1 Model Cells Identified by High-Resolution Mass Spectrometry

    doi: 10.3390/ijms232415853

    Figure Lengend Snippet: Sequence coverage map of VDAC3 from NSC34, NSC34-SOD1WT and NSC34-SOD1G93A cell lines obtained by tryptic and chymotryptic digestion. The solid line indicates the sequence that was obtained from tryptic peptides; dotted lines: sequence obtained from chymotryptic peptides. Unique tryptic (indicated in bold and blue) and chymotryptic (indicated in bold and black) peptides originating from missed cleavages were used to distinguish and cover the sequences shared by isoforms. Sequences shared by multiple isoforms are shown in red. Sequence numbering considered the starting methionine residue, which is eliminated during protein maturation.

    Article Snippet: NSC34 cell lines (mouse motor neuron-like) obtained from CELLutions Biosystem Inc. were stably transfected with pTet-ON plasmid (Clontech, Mountain View, CA, USA) harboring sequences encoding human SOD1 wt (NSC34-SOD1WT) or G93A (NSC34-SOD1G93A) and used as non-ALS motor neuron line and ALS motor neuron line, respectively [ ].

    Techniques: Sequencing, Residue

    Ox/Red ratio (average and standard deviation) of the absolute intensities of the molecular ions of sulfur containing tryptic peptides found in the analysis of VDAC3 from NSC34, NSC34-SOD1WT,  NSC34-SOD1G93A   cell lines  reduced with DTT, carboxyamidomethylated and digested in-solution.

    Journal: International Journal of Molecular Sciences

    Article Title: Specific Post-Translational Modifications of VDAC3 in ALS-SOD1 Model Cells Identified by High-Resolution Mass Spectrometry

    doi: 10.3390/ijms232415853

    Figure Lengend Snippet: Ox/Red ratio (average and standard deviation) of the absolute intensities of the molecular ions of sulfur containing tryptic peptides found in the analysis of VDAC3 from NSC34, NSC34-SOD1WT, NSC34-SOD1G93A cell lines reduced with DTT, carboxyamidomethylated and digested in-solution.

    Article Snippet: NSC34 cell lines (mouse motor neuron-like) obtained from CELLutions Biosystem Inc. were stably transfected with pTet-ON plasmid (Clontech, Mountain View, CA, USA) harboring sequences encoding human SOD1 wt (NSC34-SOD1WT) or G93A (NSC34-SOD1G93A) and used as non-ALS motor neuron line and ALS motor neuron line, respectively [ ].

    Techniques: Standard Deviation, Sequencing

    Ox/Red ratio (average and standard deviation) of the absolute intensities of the molecular ions of sulfur containing chymotryptic peptides found in the analysis of VDAC3 from NSC34, NSC34-SOD1WT,  NSC34-SOD1G93A   cell lines  reduced with DTT, carboxyamidomethylated and digested in-solution.

    Journal: International Journal of Molecular Sciences

    Article Title: Specific Post-Translational Modifications of VDAC3 in ALS-SOD1 Model Cells Identified by High-Resolution Mass Spectrometry

    doi: 10.3390/ijms232415853

    Figure Lengend Snippet: Ox/Red ratio (average and standard deviation) of the absolute intensities of the molecular ions of sulfur containing chymotryptic peptides found in the analysis of VDAC3 from NSC34, NSC34-SOD1WT, NSC34-SOD1G93A cell lines reduced with DTT, carboxyamidomethylated and digested in-solution.

    Article Snippet: NSC34 cell lines (mouse motor neuron-like) obtained from CELLutions Biosystem Inc. were stably transfected with pTet-ON plasmid (Clontech, Mountain View, CA, USA) harboring sequences encoding human SOD1 wt (NSC34-SOD1WT) or G93A (NSC34-SOD1G93A) and used as non-ALS motor neuron line and ALS motor neuron line, respectively [ ].

    Techniques: Standard Deviation, Sequencing

    MS/MS spectrum of the doubly charged molecular ion at m/z 660.2664 (calculated 660.2663) of the N-terminal tryptic peptide of VDAC3 from NSC34-SOD1WT cell line with cysteine residue 2 in the form of sulfonic acid and cysteine residue 8 in the carboxyamidomethylated form. The inset shows the full scan mass spectrum of the molecular ion. Fragment ions originating from the neutral loss of H 2 O are indicated by an asterisk. The fragment ion originating from the neutral loss of NH 3 is indicated by two asterisks.

    Journal: International Journal of Molecular Sciences

    Article Title: Specific Post-Translational Modifications of VDAC3 in ALS-SOD1 Model Cells Identified by High-Resolution Mass Spectrometry

    doi: 10.3390/ijms232415853

    Figure Lengend Snippet: MS/MS spectrum of the doubly charged molecular ion at m/z 660.2664 (calculated 660.2663) of the N-terminal tryptic peptide of VDAC3 from NSC34-SOD1WT cell line with cysteine residue 2 in the form of sulfonic acid and cysteine residue 8 in the carboxyamidomethylated form. The inset shows the full scan mass spectrum of the molecular ion. Fragment ions originating from the neutral loss of H 2 O are indicated by an asterisk. The fragment ion originating from the neutral loss of NH 3 is indicated by two asterisks.

    Article Snippet: NSC34 cell lines (mouse motor neuron-like) obtained from CELLutions Biosystem Inc. were stably transfected with pTet-ON plasmid (Clontech, Mountain View, CA, USA) harboring sequences encoding human SOD1 wt (NSC34-SOD1WT) or G93A (NSC34-SOD1G93A) and used as non-ALS motor neuron line and ALS motor neuron line, respectively [ ].

    Techniques: Tandem Mass Spectroscopy, Residue

    Ox/Red ratio (average and standard deviation) of the absolute intensities of the molecular ions of tryptic peptides containing succinated and non-succinated cysteines found in the analysis of VDAC3 from NSC34, NSC34-SOD1WT,  NSC34-SOD1G93A   cell lines  reduced with DTT, carboxyamidomethylated and digested in-solution.

    Journal: International Journal of Molecular Sciences

    Article Title: Specific Post-Translational Modifications of VDAC3 in ALS-SOD1 Model Cells Identified by High-Resolution Mass Spectrometry

    doi: 10.3390/ijms232415853

    Figure Lengend Snippet: Ox/Red ratio (average and standard deviation) of the absolute intensities of the molecular ions of tryptic peptides containing succinated and non-succinated cysteines found in the analysis of VDAC3 from NSC34, NSC34-SOD1WT, NSC34-SOD1G93A cell lines reduced with DTT, carboxyamidomethylated and digested in-solution.

    Article Snippet: NSC34 cell lines (mouse motor neuron-like) obtained from CELLutions Biosystem Inc. were stably transfected with pTet-ON plasmid (Clontech, Mountain View, CA, USA) harboring sequences encoding human SOD1 wt (NSC34-SOD1WT) or G93A (NSC34-SOD1G93A) and used as non-ALS motor neuron line and ALS motor neuron line, respectively [ ].

    Techniques: Standard Deviation, Sequencing

    Ox/Red ratio (average and standard deviation) of the absolute intensities of the molecular ions of tryptic peptides containing deamidated and non-deamidated asparagine found in the analysis of VDAC3 from  NSC34-SOD1G93A  cell line reduced with DTT, carboxyamidomethylated and digested in-solution.

    Journal: International Journal of Molecular Sciences

    Article Title: Specific Post-Translational Modifications of VDAC3 in ALS-SOD1 Model Cells Identified by High-Resolution Mass Spectrometry

    doi: 10.3390/ijms232415853

    Figure Lengend Snippet: Ox/Red ratio (average and standard deviation) of the absolute intensities of the molecular ions of tryptic peptides containing deamidated and non-deamidated asparagine found in the analysis of VDAC3 from NSC34-SOD1G93A cell line reduced with DTT, carboxyamidomethylated and digested in-solution.

    Article Snippet: NSC34 cell lines (mouse motor neuron-like) obtained from CELLutions Biosystem Inc. were stably transfected with pTet-ON plasmid (Clontech, Mountain View, CA, USA) harboring sequences encoding human SOD1 wt (NSC34-SOD1WT) or G93A (NSC34-SOD1G93A) and used as non-ALS motor neuron line and ALS motor neuron line, respectively [ ].

    Techniques: Standard Deviation, Sequencing

    MS/MS spectrum of the doubly charged molecular ion at m/z 924.9586 (calculated 924.9582) of the VDAC3 tryptic peptide from NSC34-SOD1G93A cell line containing the asparagine residue 215 in the deamidated form. The inset shows the full scan mass spectrum of molecular ion. Fragment ions originated from the neutral loss of H 2 O are indicated by an asterisk. Fragment ions originated from the neutral loss of NH 3 are indicated by two asterisks.

    Journal: International Journal of Molecular Sciences

    Article Title: Specific Post-Translational Modifications of VDAC3 in ALS-SOD1 Model Cells Identified by High-Resolution Mass Spectrometry

    doi: 10.3390/ijms232415853

    Figure Lengend Snippet: MS/MS spectrum of the doubly charged molecular ion at m/z 924.9586 (calculated 924.9582) of the VDAC3 tryptic peptide from NSC34-SOD1G93A cell line containing the asparagine residue 215 in the deamidated form. The inset shows the full scan mass spectrum of molecular ion. Fragment ions originated from the neutral loss of H 2 O are indicated by an asterisk. Fragment ions originated from the neutral loss of NH 3 are indicated by two asterisks.

    Article Snippet: NSC34 cell lines (mouse motor neuron-like) obtained from CELLutions Biosystem Inc. were stably transfected with pTet-ON plasmid (Clontech, Mountain View, CA, USA) harboring sequences encoding human SOD1 wt (NSC34-SOD1WT) or G93A (NSC34-SOD1G93A) and used as non-ALS motor neuron line and ALS motor neuron line, respectively [ ].

    Techniques: Tandem Mass Spectroscopy, Residue

    Ox/Red ratio (average and standard deviation) of the absolute intensities of the molecular ions of tryptic peptides containing succinimide intermediate found in the analysis of VDAC3 from NSC34, NSC34-SOD1WT,  NSC34-SOD1G93A   cell lines  reduced with DTT, carboxyamidomethylated and digested in-solution.

    Journal: International Journal of Molecular Sciences

    Article Title: Specific Post-Translational Modifications of VDAC3 in ALS-SOD1 Model Cells Identified by High-Resolution Mass Spectrometry

    doi: 10.3390/ijms232415853

    Figure Lengend Snippet: Ox/Red ratio (average and standard deviation) of the absolute intensities of the molecular ions of tryptic peptides containing succinimide intermediate found in the analysis of VDAC3 from NSC34, NSC34-SOD1WT, NSC34-SOD1G93A cell lines reduced with DTT, carboxyamidomethylated and digested in-solution.

    Article Snippet: NSC34 cell lines (mouse motor neuron-like) obtained from CELLutions Biosystem Inc. were stably transfected with pTet-ON plasmid (Clontech, Mountain View, CA, USA) harboring sequences encoding human SOD1 wt (NSC34-SOD1WT) or G93A (NSC34-SOD1G93A) and used as non-ALS motor neuron line and ALS motor neuron line, respectively [ ].

    Techniques: Standard Deviation, Sequencing

    Retention time, experimentally measured and calculated monoisotopic m/z of the molecular ions, position in the sequence, absolute intensities and peptide sequence of tryptic fragment containing asparagine residue 76 in succinimide intermediate form and asparagine residue 79 in isoaspartate methyl ester form found in the analysis of VDAC3 from NSC34 and  NSC34-SOD1WT   cell lines  reduced with DTT, carboxyamidomethylated and digested in-solution.

    Journal: International Journal of Molecular Sciences

    Article Title: Specific Post-Translational Modifications of VDAC3 in ALS-SOD1 Model Cells Identified by High-Resolution Mass Spectrometry

    doi: 10.3390/ijms232415853

    Figure Lengend Snippet: Retention time, experimentally measured and calculated monoisotopic m/z of the molecular ions, position in the sequence, absolute intensities and peptide sequence of tryptic fragment containing asparagine residue 76 in succinimide intermediate form and asparagine residue 79 in isoaspartate methyl ester form found in the analysis of VDAC3 from NSC34 and NSC34-SOD1WT cell lines reduced with DTT, carboxyamidomethylated and digested in-solution.

    Article Snippet: NSC34 cell lines (mouse motor neuron-like) obtained from CELLutions Biosystem Inc. were stably transfected with pTet-ON plasmid (Clontech, Mountain View, CA, USA) harboring sequences encoding human SOD1 wt (NSC34-SOD1WT) or G93A (NSC34-SOD1G93A) and used as non-ALS motor neuron line and ALS motor neuron line, respectively [ ].

    Techniques: Sequencing, Residue